Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels

Neuroendocrinology

Volumn 94, Issue 4, 2011, Pages 313-322

  Wahjoepramono, Eka J ^a,c   Wijaya, Linda K ^a,b,c   Taddei, Kevin ^a,b   Bates, Kristyn A ^a,b   Howard, Matthew ^a,b   Martins, Georgia ^a,b   Deruyck, Karl ^a,b   Matthews, Paul M ^d   Verdile, Giuseppe ^a,b   Martins, Ralph N ^a,b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PELITA HARAPAN UNIVERSITY   (Indonesia)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Aging; Alzheimer's disease; Beta amyloid; Brain; Cerebrospinal fluid; Cortical placement; GDX; Gonadectomy; Guinea pig; Luteinizing hormone

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN LEVEL; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GONADECTOMY; GUINEA PIG; HORMONE RESPONSE; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN METABOLISM; RECEPTOR UPREGULATION;

EID: 83655191949     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000330812     Document Type: Article

References (40)

1. Bowen RL, Isley JP, Atkinson RL: An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 2000; 12: 351-354. (Pubitemid 30156528)
2. Short RA, Bowen RL, O'Brien PC, Graff-Radford NR: Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc 2001; 76: 906-909. (Pubitemid 32825912)
3. Rodrigues MA, Verdile G, Foster JK, Hogervorst E, Joesbury K, Dhaliwal S, Corder EH, Laws SM, Hone E, Prince R, Devine A, Mehta P, Beilby J, Atwood CS, Martins RN: Gonadotropins and cognition in older women. J Alzheimers Dis 2008; 13: 267-274. (Pubitemid 352039028)
4. Verdile G, Yeap BB, Clarnette RM, Dhaliwal S, Burkhardt MS, Chubb SA, De Ruyck K, Rodrigues M, Mehta PD, Foster JK, Bruce DG, Martins RN: Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men. J Alzheimers Dis 2008; 14: 201-208. (Pubitemid 352040037)
5. Bowen RL, Smith MA, Harris PL, Kubat Z, Martins RN, Castellani RJ, Perry G, Atwood CS: Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res 2002; 70: 514-518. (Pubitemid 35222388)
6. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS: Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem 2004; 279: 20539-20545. (Pubitemid 38623501)
7. Casadesus G, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, Smith MA: Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 2006; 1762: 447-452. (Pubitemid 43344306)
8. Heller H, Hasan SH, Saifi AQ: Antidiuretic activity in the cerebrospinal fluid. J Endocrinol 1968; 41: 273-280.
9. Knowles F: Ependyma of the third ventricle in relation to pituitary function. Prog Brain Res 1972; 38: 255-270.
10. Lukacs H, Hiatt ES, Lei ZM, Rao CV: Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav 1995; 29: 42-58.
11. Barron AM, Verdile G, Taddei K, Bates KA, Martins RN: Effect of chronic hCG administration on Alzheimer's-related cognition and A beta accumulation in PS1KI mice. Endocrinology 2010; 151: 5380-5388.
12. Berry A, Tomidokoro Y, Ghiso J, Thornton J: Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats. Horm Behav 2008; 54: 143-152.
13. Liu T, Wimalasena J, Bowen RL, Atwood CS: Luteinizing hormone receptor mediates neuronal pregnenolone production via upregulation of steroidogenic acute regulatory protein expression. J Neurochem 2007; 100: 1329-1339.
14. Mukai H, Tsurugizawa T, Ogiue-Ikeda M, Murakami G, Hojo Y, Ishii H, Kimoto T, Kawato S: Local neurosteroid production in the hippocampus: influence on synaptic plasticity of memory. Neuroendocrinology 2006; 84: 255-263. (Pubitemid 46391716)
15. Murakami G, Tanabe N, Ishii HT, Ogiue-Ikeda M, Tsurugizawa T, Mukai H, Hojo Y, Takata N, Furukawa A, Kimoto T, Kawato S: Role of cytochrome p450 in synaptocrinology: endogenous estrogen synthesis in the brain hippocampus. Drug Metab Rev 2006; 38: 353-369. (Pubitemid 44167195)
16. Webber KM, Stocco DM, Casadesus G, Bowen RL, Atwood CS, Previll LA, Harris PL, Zhu X, Perry G, Smith MA: Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease. Mol Neurodegener 2006; 1: 14.
17. Wilson AC, Salamat MS, Haasl RJ, Roche KM, Karande A, Meethal SV, Terasawa E, Bowen RL, Atwood CS: Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. J Endocrinol 2006; 191: 651-663. (Pubitemid 46210290)
18. Lei ZM, Rao CV, Kornyei JL, Licht P, Hiatt ES: Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 1993; 132: 2262-2270. (Pubitemid 23133280)
19. Beck M, Muller D, Bigl V: Amyloid precursor protein in guinea pigs-complete cDNA sequence and alternative splicing. Biochim Biophys Acta 1997; 1351: 17-21. (Pubitemid 27117462)
20. Johnstone EM, Chaney MO, Norris FH, Pascual R, Little SP: Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res 1991; 10: 299-305.
21. Petanceska SS, Nagy V, Frail D, Gandy S: Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp Gerontol 2000; 35: 1317-1325.
22. Wahjoepramono EJ, Wijaya LK, Taddei K, Martins G, Howard M, de Ruyck K, Bates K, Dhaliwal SS, Verdile G, Carruthers M, Martins RN: Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-beta levels. J Alzheimers Dis 2008; 15: 129-137.
23. Rapisarda C, Bacchelli B: The brain of the guinea pig in stereotaxic coordinates. Arch Sci Biol (Bologna) 1977; 61: 1-37.
24. Schmidt SD, Jiang Y, Nixon RA, Mathews PM: Tissue processing prior to protein analysis and amyloid-beta quantitation. Methods Mol Biol 2005; 299: 267-278.
25. Schmidt SD, Nixon RA, Mathews PM: ELISA method for measurement of amyloid-beta levels. Methods Mol Biol 2005; 299: 279-297.
26. Mehta PD, Capone G, Jewell A, Freedland RL: Increased amyloid [beta] protein levels in children and adolescents with Down syndrome. J Neurol Sci 2007; 254: 22-27. (Pubitemid 46330403)
27. Mathews PM, Jiang Y, Schmidt SD, Grbovic OM, Mercken M, Nixon RA: Calpain activity regulates the cell surface distribution of amyloid precursor protein. J Biol Chem 2002; 277: 36415-36424.
28. Chia WJ, Jenner AM, Farooqui AA, Ong WY: Changes in cytochrome P450 side chain cleavage expression in the rat hippocampus after kainate injury. Exp Brain Res 2008; 186: 143-149. (Pubitemid 351326969)
29. Kimoto T, Tsurugizawa T, Ohta Y, Makino J, Tamura H, Hojo Y, Takata N, Kawato S: Neurosteroid synthesis by cytochrome p450-containing systems localized in the rat brain hippocampal neurons: N-methyl-Daspartate and calcium-dependent synthesis. Endocrinology 2001; 142: 3578-3589. (Pubitemid 32681768)
30. Rosario ER, Carroll J, Pike CJ: Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res 2010; 1359: 281-290.
31. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ: Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci 2006; 26: 13384-13389. (Pubitemid 46011649)
32. Porayette P, Gallego MJ, Kaltcheva MM, Meethal SV, Atwood CS: Amyloid-beta precursor protein expression and modulation in human embryonic stem cells: a novel role for human chorionic gonadotropin. Biochem Biophys Res Commun 2007; 364: 522-527. (Pubitemid 350030920)
33. Porayette P, Gallego MJ, Kaltcheva MM, Bowen RL, Vadakkadath Meethal S, Atwood CS: Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J Biol Chem 2009; 284: 23806-23817.
34. Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN: Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol Psychiatry 2009; 14: 469-486.
35. Scott IS, Charlton HM, Cox BS, Grocock CA, Sheffield JW, O'Shaughnessy PJ: Effect of LH injections on testicular steroidogenesis, cholesterol side-chain cleavage P450 mRNA content and Leydig cell morphology in hypogonadal mice. J Endocrinol 1990; 125: 131-138. (Pubitemid 20129799)
36. Luo L, Chen H, Zirkin BR: Temporal relationships among testosterone production, steroidogenic acute regulatory protein (StAR), and P450 side-chain cleavage enzyme (P450scc) during Leydig cell aging. J Androl 2005; 26: 25-31. (Pubitemid 39665272)
37. Rekawiecki R, Nowik M, Kotwica J: Stimulatory effect of LH, PGE2 and progesterone on StAR protein, cytochrome P450 cholesterol side chain cleavage and 3beta hydroxysteroid dehydrogenase gene expression in bovine luteal cells. Prostaglandins Other Lipid Mediat 2005; 78: 169-184. (Pubitemid 41636841)
38. Lin J, Li X, Yuan F, Lin L, Cook CL, Rao ChV, Lei Z: Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2010; 69: 253-261.
39. Lee C, Ji IJ, Ji TH: Use of defined-function mutants to access receptor-receptor interactions. Methods 2002; 27: 318-323.
40. Yarram SJ, Perry MJ, Christopher TJ, Westby K, Brown NL, Lamminen T, Rulli SB, Zhang FP, Huhtaniemi I, Sandy JR, Mansell JP: Luteinizing hormone receptor knockout (LuRKO) mice and transgenic hCG-overexpressing mice (hCG alphabeta+) have bone phenotypes. Endocrinology 2003; 144: 3555-3564. (Pubitemid 36904435)